Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomised double blind placebo controlled multicentre study.
Author | |
---|---|
Abstract | :
Daily administration of rectal formulations of mesalazine is effective in preventing relapse of ulcerative proctitis. Maintenance of remission with lower doses would be an advantage. |
Year of Publication | :
1998
|
Journal | :
Gut
|
Volume | :
42
|
Issue | :
2
|
Number of Pages | :
195-9
|
ISSN Number | :
0017-5749
|
URL | :
https://gut.bmj.com/lookup/pmidlookup?view=long&pmid=9536943
|
DOI | :
10.1136/gut.42.2.195
|
Short Title | :
Gut
|
Download citation |